Abnormalities in myelination of the superior cerebellar peduncle in patients with schizophrenia and deficits in movement sequencing
Jazyk angličtina Země Spojené státy americké Médium print
Typ dokumentu časopisecké články, práce podpořená grantem
- MeSH
- analýza rozptylu MeSH
- anizotropie MeSH
- bílá hmota patologie MeSH
- dospělí MeSH
- lidé MeSH
- mladý dospělý MeSH
- mozeček patologie MeSH
- nervové dráhy patologie MeSH
- neurologické vyšetření MeSH
- počítačové zpracování obrazu MeSH
- pohyb fyziologie MeSH
- pohybové poruchy etiologie patologie MeSH
- pons patologie MeSH
- schizofrenie komplikace patologie MeSH
- studie případů a kontrol MeSH
- zobrazování difuzních tenzorů MeSH
- Check Tag
- dospělí MeSH
- lidé MeSH
- mladý dospělý MeSH
- mužské pohlaví MeSH
- ženské pohlaví MeSH
- Publikační typ
- časopisecké články MeSH
- práce podpořená grantem MeSH
Deficits in the execution of a sequence of movements are common in schizophrenia. Previous studies reported reduced functional activity in the motor cortex and cerebellum in schizophrenic patients with deficits in movement sequencing. The corticospinal tract (CST) and superior cerebellar peduncle (SCP) are fiber tracts that are involved in movement sequencing. However, the integrity of these tracts has not been evaluated in schizophrenic patients with respect to the performance of movement sequencing yet. Diffusion tensor magnetic resonance images (DT-MRI) were acquired from 24 patients with schizophrenia and 23 matched control subjects. Tractography was applied to reconstruct the CST and SCP and DT-MRI-specific parameters such as fractional anisotropy (FA) and radial diffusivity (RD) were reported. The patient group was further subdivided based on the score of sequencing of complex motor acts subscale of the Neurological Evaluation Scale into those with deficits in sequencing motor acts, the SQ(abn) group (n = 7), and those with normal performance, the SQ(norm) group (n = 17). Schizophrenia patients of the SQ(norm) subgroup had significantly reduced FA and increased RD values in the right CST in comparison to the control group; the SQ(abn) subgroup did not differ from the controls. However, the SQ(abn) subgroup showed impaired integrity of the left SCP, whereas the SQ(norm) subgroup did not. Abnormalities in the right CST in the SQ(norm) and in the left SCP in SQ(abn) groups suggest that the patients with SQ(abn) represent subgroups with distinct deficits. Moreover, these results demonstrate the involvement of the SCP in the pathogenesis of movement sequencing in schizophrenia.
Zobrazit více v PubMed
Psychiatry Res. 2008 Aug 30;163(3):193-200 PubMed
Biol Psychiatry. 2010 Jul 1;68(1):70-7 PubMed
Psychiatry Res. 1989 Mar;27(3):335-50 PubMed
Neuroradiology. 2008 Apr;50(4):285-92 PubMed
Brain. 2006 Jul;129(Pt 7):1859-71 PubMed
J Magn Reson Imaging. 2010 Oct;32(4):809-17 PubMed
NMR Biomed. 2002 Nov-Dec;15(7-8):435-55 PubMed
BMC Psychiatry. 2012 Mar 12;12:17 PubMed
Behav Res Methods. 2009 Nov;41(4):1149-60 PubMed
J Clin Psychiatry. 1998;59 Suppl 20:22-33;quiz 34-57 PubMed
Brain Res Rev. 2011 Jan 7;66(1-2):5-15 PubMed
J Magn Reson Imaging. 2013 Apr;37(4):836-45 PubMed
Int J Neuropsychopharmacol. 2007 Aug;10(4):499-502 PubMed
Neuroimage. 2010 Jan 1;49(1):199-204 PubMed
Schizophr Res. 2004 Sep 1;70(1):19-26 PubMed
PLoS One. 2011 Apr 14;6(4):e18652 PubMed
Schizophr Res. 2006 Sep;86(1-3):172-80 PubMed
Neurosci Lett. 2003 Sep 18;348(3):135-8 PubMed
Neuroimage. 2003 Nov;20(3):1714-22 PubMed
Psychiatry Res. 2009 Aug 30;173(2):83-7 PubMed
Schizophr Res. 2008 Apr;101(1-3):106-10 PubMed
Nord J Psychiatry. 2002;56(6):425-31 PubMed
Brain Res Rev. 2008 Nov;59(1):185-200 PubMed
Cerebellum. 2005;4(2):123-7 PubMed
Biol Psychiatry. 2003 Jun 15;53(12):1075-85 PubMed
J Neuroimaging. 2013 Oct;23(4):452-62 PubMed
Biophys J. 1994 Jan;66(1):259-67 PubMed
Schizophr Bull. 2005 Oct;31(4):962-77 PubMed
Schizophr Bull. 2010 Nov;36(6):1089-104 PubMed
Schizophr Res. 2012 Aug;139(1-3):144-50 PubMed
AJNR Am J Neuroradiol. 2009 Nov;30(10):1963-70 PubMed
Acta Psychiatr Scand Suppl. 1970;212:11-9 PubMed
Curr Opin Neurobiol. 2004 Apr;14(2):225-32 PubMed
Neuroimage. 2005 May 15;26(1):132-40 PubMed
Brain Res Cogn Brain Res. 2004 Oct;21(2):193-205 PubMed
Schizophr Bull. 2012 Nov;38(6):1170-9 PubMed
Neuroimage. 2013 Jan 15;65:476-87 PubMed
Schizophr Bull. 2000;26(2):367-78 PubMed
Br J Psychiatry Suppl. 2002 Sep;43:s50-7 PubMed
Med Image Comput Comput Assist Interv. 2009;12(Pt 1):919-26 PubMed
Acta Psychiatr Scand. 1999 Aug;100(2):119-25 PubMed
Schizophr Bull. 1998;24(2):203-18 PubMed
Br J Psychiatry. 1989 May;154:672-6 PubMed
Neuroimage. 2012 Feb 15;59(4):4032-43 PubMed
Prog Neuropsychopharmacol Biol Psychiatry. 2006 Dec 30;30(8):1408-12 PubMed
Neurobiol Dis. 2006 Mar;21(3):531-40 PubMed
Psychiatry Res. 2001 Oct 1;107(3):125-34 PubMed
Br J Psychiatry. 2009 Oct;195(4):346-53 PubMed
Proc Natl Acad Sci U S A. 2001 Apr 10;98(8):4746-51 PubMed
J Magn Reson Imaging. 2011 Dec;34(6):1430-8 PubMed
J Neurosci. 1995 May;15(5 Pt 1):3284-306 PubMed
Magn Reson Med. 2000 Oct;44(4):625-32 PubMed
Cerebellum. 2011 Jun;10(2):233-44 PubMed
Cerebellum. 2010 Mar;9(1):124-35 PubMed
Schizophr Res. 2004 Apr 1;67(2-3):269-75 PubMed
Biol Psychiatry. 1999 Sep 1;46(5):703-11 PubMed
Schizophr Bull. 2008 Jan;34(1):155-72 PubMed
Neuroradiology. 2007 Oct;49(10):849-63 PubMed
Lancet. 2003 Sep 6;362(9386):798-805 PubMed
Eur Arch Psychiatry Clin Neurosci. 2010 Aug;260(5):419-26 PubMed
Biol Psychiatry. 2009 Dec 1;66(11):1067-9 PubMed
J Neuroradiol. 2007 May;34(2):115-28 PubMed
Ann Neurol. 1999 Feb;45(2):265-9 PubMed
Brain. 2009 Sep;132(Pt 9):2437-48 PubMed
Arch Gen Psychiatry. 2007 Nov;64(11):1270-80 PubMed
J Psychiatry Neurosci. 2012 Sep;37(5):305-12 PubMed
Neurosci Lett. 2006 May 8;398(3):189-94 PubMed
Schizophr Res. 2012 Apr;136(1-3):55-62 PubMed
Biol Psychiatry. 2001 Jan 1;49(1):20-7 PubMed